Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Pathways

NATEGLINIDE PHARMACOKINETICS PATHWAY (PW:0000727)

View Ontology Report

Description

Nateglinide is an anti-diabetic drug used as a blocker of the ATP-sensitive potassium channels (KATP) to promote insulin secretion and lower blood glucose levels in patients with type 2 diabetes mellitus (T2D). In response to elevated levels of circulating glucose; insulin is secreted from the pancreatic beta cells. This effect is counteracted by glucagon when the glucose levels are low - the two hormones act to maintain glucose homeostasis. The secretion of insulin from the isl

Pathway Diagram:

Ariadne Genomics Inc. uptaken nateglinide nateglinide and metabolites excretion nateglinide ---> uptaken nateglinide nateglinide metabolites ---> nateglinide and metabolites excretion CYP2C9 ---> nateglinide metabolites CYP3A4 ---> nateglinide metabolites nateglinide nateglinide metabolites CYP3A4 SLCO1B1 CYP2C9
GO TO:

Genes in Pathway:


show annotations for term's descendants           Sort by:
nateglinide pharmacokinetics pathway term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 ISO RGD PMID:17253883 RGD:2316509 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
JBrowse link

Additional Elements in Pathway:

(includes Gene Groups, Small Molecules, Other Pathways..etc.)
Object TypePathway ObjectPathway Object Description
Small Moleculenateglinidenateglinide

Pathway Gene Annotations

Disease Annotations Associated with Genes in the nateglinide pharmacokinetics pathway
Pathway Annotations Associated with Genes in the nateglinide pharmacokinetics pathway
Pathway TermsGene Symbols
artemether pharmacokinetics pathwayCyp3a2
axitinib pharmacokinetics pathwayCyp3a2
caffeine pharmacokinetics pathwayCyp3a2
carbamazepine pharmacokinetics pathwayCyp3a2
celecoxib pharmacodynamics pathwayCyp3a2
celecoxib pharmacokinetics pathwayCyp3a2
clomipramine pharmacokinetics pathwayCyp3a2
clopidogrel pharmacodynamics pathwayCyp3a2
clopidogrel pharmacokinetics pathwayCyp3a2
codeine and morphine pharmacodynamics pathwayCyp3a2
codeine and morphine pharmacokinetics pathwayCyp3a2
cyclophosphamide pharmacodynamics pathwayCyp3a2
cyclophosphamide pharmacokinetics pathwayCyp3a2
doxepin pharmacokinetics pathwayCyp3a2
etoposide pharmacodynamics pathwayCyp3a2
etoposide pharmacokinetics pathwayCyp3a2
felbamate pharmacokinetics pathwayCyp3a2
fluoxetine pharmacodynamics pathwayCyp3a2
fluoxetine pharmacokinetics pathwayCyp3a2
gefitinib pharmacokinetics pathwayCyp3a2
ibuprofen pharmacodynamics pathwayCyp3a2
ibuprofen pharmacokinetics pathwayCyp3a2
ifosfamide pharmacodynamics pathwayCyp3a2
ifosfamide pharmacokinetics pathwayCyp3a2
imipramine pharmacodynamics pathwayCyp3a2
imipramine pharmacokinetics pathwayCyp3a2
irinotecan pharmacodynamics pathwayCyp3a2
irinotecan pharmacokinetics pathwayCyp3a2
lidocaine pharmacodynamics pathwayCyp3a2
lidocaine pharmacokinetics pathwayCyp3a2
linoleic acid metabolic pathwayCyp3a2
losartan pharmacokinetics pathwayCyp3a2
methadone pharmacodynamics pathwayCyp3a2
methadone pharmacokinetics pathwayCyp3a2
mycophenolic acid pharmacokinetics pathwayCyp3a2
nateglinide pharmacokinetics pathwayCyp3a2
neviparine pharmacokinetics pathwayCyp3a2
paracetamol pharmacokinetics pathwayCyp3a2
phase I biotransformation pathway via cytochrome P450Cyp3a2
phenytoin pharmacodynamics pathwayCyp3a2
prednisone pharmacodynamics pathwayCyp3a2
prednisone pharmacokinetics pathwayCyp3a2
repaglinide pharmacokinetics pathwayCyp3a2
retinol metabolic pathwayCyp3a2
sorafenib pharmacokinetics pathwayCyp3a2
statin pharmacokinetics pathwayCyp3a2
steroid hormone biosynthetic pathwayCyp3a2
tamoxifen pharmacodynamics pathwayCyp3a2
tamoxifen pharmacokinetics pathwayCyp3a2
teniposide pharmacodynamics pathwayCyp3a2
teniposide pharmacokinetics pathwayCyp3a2
tramadol pharmacokinetics pathwayCyp3a2
venlafaxine pharmacokinetics pathwayCyp3a2
vinblastine pharmacodynamics pathwayCyp3a2
vinorelbine pharmacodynamics pathwayCyp3a2
vitamin A deficiency pathwayCyp3a2
warfarin pharmacokinetics pathwayCyp3a2

References Associated with the nateglinide pharmacokinetics pathway:

Ontology Path Diagram:

paths to the root
paths to the root

Import into Pathway Studio: